The Benefit of Generic Drug User Fees
Richard L. Schilsky, MD, from University of Chicago Comprehensive Cancer Center, explains the benefit to generic drug user fees.
Richard L. Schilsky, MD, Chief of Hematology/Oncology in the Department of Medicine and Deputy Director of the University of Chicago Comprehensive Cancer Center, explains the benefit to generic drug user fees.
In the world, 70% of all generic drugs are made by three manufacturers and 80% are made by five manufacturers. Schilsky points out that these manufacturers have a very thin profit margin on many drugs and have tough decisions to make when problems arise.
Clinical Pearls
One reason generic drug user fees are so important to the FDA is that there is a huge backlog of applications to review. The hope is that generic drug user fees will give resources to the FDA to help reduce review times.
- 70% of all generic drugs in the world are made by three manufacturers
- 80% of all generic drugs are made by five manufacturers
- Generic drug user fees will hopefully give resources to the FDA to reduce application review times
<<<
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
AI-Driven Deep Learning Model Shows Promise in Standardizing MDS Diagnosis
December 10th 2024In an interview, Palak Dave discussed how artificial intelligence, using deep learning to analyze bone marrow aspirate smear images, could standardize and accelerate the diagnosis of MDS vs pre-MDS conditions.
Read More
Systemic Therapy Choice Linked to Radiosurgery Outcomes in Brain Mets
December 6th 2024In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection impacts outcomes in patients with brain metastases, particularly those with lung cancer.
Read More
